During the last week, the collaboration has successfully tested the IRIS (ISOLPHARM Radionuclide Implantation Station) device. The system was coupled and aligned with the SPES Offline beamline in order to perform the first stable beam deposition using this device. The first test was performed using a stable copper beam. The importance of these experiments is…
Read more
We are happy to announce the publication of our new free database of voxel S-values calculated with GEANT4.
We are happy to announce the pubblication on the NuPECC journal “Nuclear Physics News Internation” of a general article onISOLPHARM named: “The ISOLPHARM Project: Production of HighSpecific Activity Medical Radioisotopes at SPES” Available at : https://www.tandfonline.com/doi/abs/10.1080/10619127.2020.1752100
Task 3 activities are currently accelerating towards the selection and development of an efficient in-vitro model overexpressing CCK2R. Measurements of the intracellular calcium increase upon stimulation of the receptor were successfully performed, thus leading to an optimized tumor model which will be further tested in 3D scaffolds.
111-Ag was produced by neutron capture in a natPd target at the LENA Laboratory TRIGA Mark II nuclear reactor (Pavia University). The spectrum was obtained by irradiating 70 mg of natural Pd for one hour in the TRIGA Central Thimble.
During 18 and 19 of September, the National Congress of GICR association was held in Padova.
This conference has become an important reference point, thanks to the high scientific profile given by international speakers, for different research fields involving medical imaging and targeted therapy with radionuclides.
